Regulaxis Competitors and Similar CompaniesClear all
Regulaxis's competitors and similar companies include Cellvation, Camino Pharma, Maravai LifeSciences and Sanofi.
 Regulaxis Regulaxis is a biotechnology company that is engaged in the research, development, and licensing of synthetic molecules for use in human treatments. |  Cellvation Cellvation is a clinical-stage biopharmaceutical company developing cellular therapeutics for the treatment of traumatic brain injury (TBI). |  Camino Pharma Camino Pharma is a company focused on discovering and developing therapies for patients with cancer and CNS disorders. |  Maravai LifeSciences Maravai LifeSciences is a life sciences company providing products to enable the development of drug therapies, diagnostics, vaccines, and support research on human diseases. |  Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. | |
Founding Date | Founding Date 2013 | Founding Date 2016 | Founding Date 2014 | Founding Date 2014 | Founding Date 1994 |
Type | Type Private | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Romainville, FR HQ Courbevoie, FR | Locations New York, US HQ | Locations San Diego, US HQ San Diego, US | Locations San Diego, US HQ Chicago, US Burlingame, US Southport, US Sterling, US | Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more |
Employees | Employees 2 | Employees 167% decrease | Employees 4 | Employees 6507% increase | Employees 82,878 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.8 b | Valuation ($) 141.1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $185.7m (FY, 2025) | Revenue (est.) €45.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $151.8m (FY, 2025) | Cost of goods €11.6b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $34m (FY, 2025) | Gross profit €37.6b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($230.8m) (FY, 2025) | Net income €8b (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 1b | Total funding raised $ 310m |
For sources of this data, please see the company profile
View Company Profiles
Cellvation
HQ
New York, US
Cellvation is a clinical-stage biopharmaceutical company developing cellular therapeutics for the treatment of traumatic brain injury (TBI).
View companyCamino Pharma
HQ
San Diego, US
Employees
4
Camino Pharma is a company focused on discovering and developing therapies for patients with cancer and CNS disorders.
View companyMaravai LifeSciences
HQ
San Diego, US
Employees
650↑ 7% increase
Maravai LifeSciences is a life sciences company providing products to enable the development of drug therapies, diagnostics, vaccines, and support research on human diseases.
View companySanofi
HQ
Paris, FR
Employees
82,878
Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
View company